These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19389556)

  • 21. Vitreous proteomic analysis of proliferative vitreoretinopathy.
    Yu J; Liu F; Cui SJ; Liu Y; Song ZY; Cao H; Chen FE; Wang WJ; Sun T; Wang F
    Proteomics; 2008 Sep; 8(17):3667-78. PubMed ID: 18752205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic retinopathy: Proteomic approaches to help the differential diagnosis and to understand the underlying molecular mechanisms.
    Csősz É; Deák E; Kalló G; Csutak A; Tőzsér J
    J Proteomics; 2017 Jan; 150():351-358. PubMed ID: 27373871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Verification of biomarkers for diabetic retinopathy by multiple reaction monitoring.
    Kim K; Kim SJ; Yu HG; Yu J; Park KS; Jang IJ; Kim Y
    J Proteome Res; 2010 Feb; 9(2):689-99. PubMed ID: 20020744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitreous proteomics and diabetic retinopathy.
    Walia S; Clermont AC; Gao BB; Aiello LP; Feener EP
    Semin Ophthalmol; 2010; 25(5-6):289-94. PubMed ID: 21091014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetic retinopathy: a preventable scourge.
    Jain S; Preetha K; Jain SC; Jain A
    J Indian Med Assoc; 2008 May; 106(5):303-4, 306. PubMed ID: 18839636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Isoelectric focusing and electroblotting of human vitreous body proteins].
    Moter H; Wiedemann P; Weller M; Heimann K
    Fortschr Ophthalmol; 1989; 86(4):399-402. PubMed ID: 2793016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficit of somatostatin in the vitreous fluid of patients with diabetic macular edema.
    Simó R; Carrasco E; Fonollosa A; García-Arumí J; Casamitjana R; Hernández C
    Diabetes Care; 2007 Mar; 30(3):725-7. PubMed ID: 17327350
    [No Abstract]   [Full Text] [Related]  

  • 28. Methods for samples preparation in proteomic research.
    Bodzon-Kulakowska A; Bierczynska-Krzysik A; Dylag T; Drabik A; Suder P; Noga M; Jarzebinska J; Silberring J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):1-31. PubMed ID: 17113834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evisceration of mouse vitreous and retina for proteomic analyses.
    Skeie JM; Tsang SH; Mahajan VB
    J Vis Exp; 2011 Apr; (50):. PubMed ID: 21490583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strain-dependent increases in retinal inflammatory proteins and photoreceptor FGF-2 expression in streptozotocin-induced diabetic rats.
    Kirwin SJ; Kanaly ST; Linke NA; Edelman JL
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5396-404. PubMed ID: 19474406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy.
    Kangas-Kontio T; Vavuli S; Kakko SJ; Penna J; Savolainen ER; Savolainen MJ; Liinamaa MJ
    Br J Ophthalmol; 2009 Oct; 93(10):1401-6. PubMed ID: 19628492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic analysis and identification of aqueous humor proteins with a pathophysiological role in diabetic retinopathy.
    Chiang SY; Tsai ML; Wang CY; Chen A; Chou YC; Hsia CW; Wu YF; Chen HM; Huang TH; Chen PH; Liu HT; Shui HA
    J Proteomics; 2012 Jun; 75(10):2950-9. PubMed ID: 22200677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomic toolbox for autoimmunity research.
    Wu T; Mohan C
    Autoimmun Rev; 2009 Jun; 8(7):595-8. PubMed ID: 19393208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prize catch for diabetic retinopathy.
    Gardner TW; Antonetti DA
    Nat Med; 2007 Feb; 13(2):131-2. PubMed ID: 17290269
    [No Abstract]   [Full Text] [Related]  

  • 35. In-Gel 18O labeling for improved identification of proteins from 2-DE Gel spots in comparative proteomic experiments.
    Broedel O; Krause E; Stephanowitz H; Schuemann M; Eravci M; Weist S; Brunkau C; Wittke J; Eravci S; Baumgartner A
    J Proteome Res; 2009 Jul; 8(7):3771-7. PubMed ID: 19425618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hares and tortoises: the high- versus low-throughput proteomic race.
    Wilkins MR
    Electrophoresis; 2009 Jun; 30 Suppl 1():S150-5. PubMed ID: 19441020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X; Wang G; Wang Y
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy.
    Silva PS; Sun JK; Aiello LP
    Semin Ophthalmol; 2009; 24(2):93-9. PubMed ID: 19373693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomics identification of oxidatively modified proteins in brain.
    Sultana R; Perluigi M; Butterfield DA
    Methods Mol Biol; 2009; 564():291-301. PubMed ID: 19544029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of steroids in the treatment of diabetic macular edema.
    Kuo CH; Gillies MC
    Int Ophthalmol Clin; 2009; 49(2):121-34. PubMed ID: 19349792
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.